Autoantibody Testing for Autoimmune Disease

Clinics in Chest Medicine

Volumn 31, Issue 3, 2010, Pages 415-422

  Self, Sally E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Autoantibody; Autoimmune; Rheumatic; Serology

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTIPERINUCLEAR FACTOR; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LA ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; POL 3 ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN; TRANSFER RNA ANTIBODY; UNCLASSIFIED DRUG;

ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ANTIBODY TITER; AUTOIMMUNE DISEASE; DERMATOMYOSITIS; DISEASE MARKER; FALSE POSITIVE RESULT; GOODPASTURE SYNDROME; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 77955410441     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2010.04.001     Document Type: Review

References (21)

1. Kroshinsky D., Stone J., Bloch D., et al. Case 5-2009: a 47-year-old woman with a rash and numbness and pain in the legs. N Engl J Med 2009, 360(7):711-720.
2. Tan E.M., Feltkamp T.E.W., Smolen J.S., et al. Range of antinuclear antibodies in " healthy" individuals. Arthritis Rheum 1997, 40:1601-1611.
3. Kumar V., Abbas A.K., Fausto N., et al. Diseases of the immune system. Kumar V, Abbas AK, Fausto N, et al. Robbins and Cotran pathologic basis of disease 2010, 215. Saunders Elsevier, Philadelphia. 8th edition.
4. Cheek W. Making sense of the ANA hodgepodge. CAP Today 2009, 23(9):1-110.
5. von Mühlen C.A., Nakamura R.M. Guidelines for selecting and using laboratory test for autoantibodies to nuclear, nucleolar, and other related cytoplasmic antigens. Clinical and laboratory evaluation of autoimmune diseases 2002, 183-198. ASCP Press, Chicago. R.M. Nakamura, D.F. Keren, D.J. Byland (Eds.).
6. Nakamura R.M., Tan E.M. Clinical and laboratory evaluation of systemic lupus erythematosus and lupus-related disorders. Clinical and laboratory evaluation of autoimmune diseases 2002, 111-139. ASCP Press, Chicago. R.M. Nakamura, D.F. Keren, D.J. Byland (Eds.).
7. Isern R.A., Yaneva M., Weiner E., et al. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992, 93:307-312.
8. von Mühlen C.A., Nakamura R.M. Clinical and laboratory evaluation of systemic rheumatic diseases. Henry's clinical diagnosis and management by laboratory methods 2007, 916-944. Saunders Elsevier, Philadelphia. 21st edition. R.A. McPherson, M.R. Pincus (Eds.).
9. Ho K.T., Reveille J.D. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003, 5:80-93.
10. Steen V.D. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2006, 35(1):35-42.
11. Svengliati B.S., Santillo M., Bevilacqua F., et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006, 354:2667-2676.
12. Schnabel A., Reuter M., Biederer J. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003, 32(5):273-284.
13. Wener M.H. Rheumatoid factors. Manual of clinical laboratory immunology 2002, 961-972. American Society for Microbiology Press, Washington, DC. 6th edition. N.R. Rose, R.G. Hamilton, B. Detrick (Eds.).
14. Vincent C., de Keyser F., Masson-Bessiere C., et al. Anti-perinuclear factor compared with the so-called " antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 1999, 58:42-48.
15. Vossenaar E.R., vanVenrooij W.J. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 2004, 6:107-111.
16. van Venrooij W.J., Prujin G.J. Citrullination, a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000, 2:249-251.
17. Mitsias D., Moutsopoulos M. Sjögren syndrome. Diagnostic criteria in autoimmune disease 2008, 37-42. Humana Press, Totowa (NJ). Y. Shoenfelk, R. Cervera, M.E. Gershwin (Eds.).
18. Hagen E.C., Daha M.R., Hermans J., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998, 53:743-753.
19. Trevisin M., Pollock W., Dimech W., et al. Antigen specific ANCA ELISAs have different sensitivities for active and treated vasculitis and for nonvasculitic disease. Am J Clin Pathol 2008, 129:42-53.
20. Girard T., Mahr A., Noël L.-H., et al. Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study. Rheumatology 2001, 40:147-151.
21. Collins A.B., Colvin R.B. Kidney and lung disease mediated by anti-glomerular basement membrane antibodies: detection by Western blot analysis. Manual of clinical laboratory immunology 2002, 1049-1053. American Society for Microbiology Press, Washington, DC. 6th edition. N.R. Rose, R.G. Hamilton, B. Detrick (Eds.).